Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera

被引：0
|
作者：
Matsuno, H
Yudoh, K
Nishioka, K
机构：
[1] Toin Yokohama Univ, Bioengn Res Ctr, Yokohama, Kanagawa, Japan
[2] St Marianna Univ, Sch Med, Inst Med Sci, Kawasaki, Kanagawa 213, Japan
来源：
ARTHRITIS RESEARCH & THERAPY | 2003年 / 5卷 / Suppl 3期
关键词：
Rheumatoid Arthritis; Peripheral Blood Mononuclear Cell; Human Peripheral Blood; Human Peripheral Blood Mononuclear Cell; Potential Therapeutic Agent;
D O I：
10.1186/ar930
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
129
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [31] Prevention of Acute Graft-Versus-Host Disease in Human/Mouse Xenogeneic SCID Mouse Model by Humanized Anti-CD74 Monoclonal Antibody, Milatuzumab
    Chen, Xiaochuan
    Chang, Chien-Hsing
    Stein, Rhona
    Cardillo, Thomas M.
    Gold, David V.
    Goldenberg, David M.
    BLOOD, 2012, 120 (21)
  • [32] INDUCTION OF APOPTOSIS IN HUMAN EOSINOPHILS BY ANTI-FAS ANTIBODY TREATMENT IN-VITRO
    MATSUMOTO, K
    SCHLEIMER, RP
    SAITO, H
    IIKURA, Y
    BOCHNER, BS
    BLOOD, 1995, 86 (04) : 1437 - 1443
  • [33] In vivo effect of humanized agonistic anti-fas antibody against adult T-cell leukemia (ATL).
    Koya, Y
    Maeda, M
    Takeda, S
    Miyazato, P
    Ohsumi, J
    Yonehara, S
    Matsuoka, M
    BLOOD, 2002, 100 (11) : 310B - 310B
  • [34] DISTRIBUTION OF APOPTOSIS-MEDIATING FAS ANTIGEN IN HUMAN SKIN AND EFFECTS OF ANTI-FAS MONOCLONAL-ANTIBODY ON HUMAN EPIDERMAL KERATINOCYTE AND SQUAMOUS-CELL CARCINOMA CELL-LINES
    OISHI, M
    MAEDA, K
    SUGIYAMA, S
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1994, 286 (07) : 396 - 407
  • [35] ANTI-FAS MONOCLONAL-ANTIBODY IS CYTOCIDAL TO HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS WITHOUT AUGMENTING VIRAL REPLICATION
    KOBAYASHI, N
    HAMAMOTO, Y
    YAMAMOTO, N
    ISHII, A
    YONEHARA, M
    YONEHARA, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) : 9620 - 9624
  • [36] Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-I fax transgenic mice
    Fujisawa, K
    Asahara, H
    Okamoto, K
    Aono, H
    Hasunuma, T
    Kobata, T
    Iwakura, Y
    Yonehara, S
    Sumida, T
    Nishioka, K
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02): : 271 - 278
  • [37] Anti-Fas IgM monoclonal antibody enhances apoptosis induced by low-dose cytosine arabinoside
    Nakamura, S
    Takeshima, M
    Nakamura, Y
    Ohtake, S
    Matsuda, T
    ANTICANCER RESEARCH, 1999, 19 (1A) : 197 - 204
  • [38] Effectiveness of humanized anti-interleukin-6 receptor monoclonal antibody (MRA) in secondary osteoporosis complicated with rheumatoid arthritis
    Saito, K
    Okada, Y
    Nakatsuka, K
    Yoshizaki, K
    Kishimoto, T
    Nishimoto, N
    Tanaka, Y
    BONE, 2003, 32 (05) : S77 - S77
  • [39] CLAZAKIZUMAB Humanized Anti-IL-6 Monoclonal Antibody Treatment of Rheumatoid Arthritis Treatment of Autoimmune Diseases Oncolytic
    Reviriego, C.
    DRUGS OF THE FUTURE, 2012, 37 (09) : 633 - 636
  • [40] HUMAN ANTI-MOUSE ANTIBODY-RESPONSE INDUCED BY ANTI-CD4 MONOCLONAL-ANTIBODY THERAPY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    HORNEFF, G
    WINKLER, T
    KALDEN, JR
    EMMRICH, F
    BURMESTER, GR
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 59 (01): : 89 - 103
12345